In-licensing: Drug discovery & Musculoskeletal

Latest: Watch here for details of new products and services.

Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Comparison
Forums: Visit our forums
Jobs: Visit our job site
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire New!
Contact us: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..3 of 3 - per page
Order by

NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More

Palau Pharma is seeking small molecules at the late preclinical stage or clinical phase I More

Palau Pharma is seeking an inflammation/autoimmune disorder commercialized drug with novel DDT, combination product More

Displaying 1..3 of 3 - per page
Order by

Industry sector: Bioinformatics; Bioinformatics; Combinatorial biology; Combinatorial chemistry; Drug research platforms; Genomics; High throughput screening; Proteomics
Therapeutic target: Age-related disorders (other); Back pain; Birth defects; Bone cancer; Chronic granulomatous disease; Dupuytren's disease; Dyskinesia; Fibrocystic breast disease; Gout; Growth disorders; Hypomobility; Intermittent claudication; Leprosy; Lupus erythematosis; Muscular; Musculoskeletal disorder (other); Scleroderma; Sjogren's syndrome; Skeletal; Trauma, physical; Wasting disease
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.